Hyaluronic acid and HYAL-1 in prostate biopsy specimens: predictors of biochemical recurrence (Q39254195)

10 September 2017

Hyaluronic acid and HYAL-1 in prostate biopsy specimens: predictors of biochemical recurrence (English)

1 reference

10 September 2017

0 references

Christopher S Gomez

1 reference

10 September 2017

Pablo Gomez

1 reference

10 September 2017

Judith Knapp

1 reference

10 September 2017

Merce Jorda

1 reference

10 September 2017

Mark S Soloway

1 reference

10 September 2017

Vinata B Lokeshwar

1 reference

10 September 2017

language of work or name

English

0 references

publication date

14 August 2009

1 reference

10 September 2017

1 reference

10 September 2017

182

1 reference

10 September 2017

1 reference

10 September 2017

1350-1356

1 reference

HYAL-1 hyaluronidase: a potential prognostic indicator for progression to muscle invasion and recurrence in bladder cancer

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2828051

Spontaneous metastasis of prostate cancer is promoted by excess hyaluronan synthesis and processing

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2828051

Molecular alterations in prostate cancer as diagnostic, prognostic, and therapeutic targets

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2828051

Osteopontin and interleukin-8 expression is independently associated with prostate cancer recurrence

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2828051

Hyaluronan and hyaluronidase in genitourinary tumors

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2828051

Hyaluronan in human tumors: pathobiological and prognostic messages from cell-associated and stromal hyaluronan

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2828051

Hyalurondiase: both a tumor promoter and suppressor

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2828051

Therapeutic options for hormone-refractory prostate cancer in 2007.

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2828051

Inducible hyaluronan production reveals differential effects on prostate tumor cell growth and tumor angiogenesis

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2828051

Comparison of the prognostic potential of hyaluronic acid, hyaluronidase (HYAL-1), CD44v6 and microvessel density for prostate cancer

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2828051

Evaluation of the prognostic potential of hyaluronic acid and hyaluronidase (HYAL1) for prostate cancer

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2828051

Androgen receptor regulates CD168 expression and signaling in prostate cancer

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2828051

HYAL1 hyaluronidase in prostate cancer: a tumor promoter and suppressor

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2828051

HYAL1 hyaluronidase: a molecular determinant of bladder tumor growth and invasion

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2828051

Association of elevated levels of hyaluronidase, a matrix-degrading enzyme, with prostate cancer progression

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2828051

Hyaluronic acid synthase-1 expression regulates bladder cancer growth, invasion, and angiogenesis through CD44.

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2828051

A side by side comparison of cytology and biomarkers for bladder cancer detection

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2828051

Strong Stromal Hyaluronan Expression Is Associated with PSA Recurrence in Local Prostate Cancer

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2828051

High stromal hyaluronan level is associated with poor differentiation and metastasis in prostate cancer

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2828051

EAU guidelines on prostate cancer

21 August 2018

1 reference

12 December 2020

p53 and bcl-2 immunohistochemistry in pretreatment prostate needle biopsies to predict recurrence of prostate cancer after radical prostatectomy

1 reference

12 December 2020

Urinary hyaluronic acid and hyaluronidase: markers for bladder cancer detection and evaluation of grade

1 reference

12 December 2020

Identification of bladder tumor-derived hyaluronidase: its similarity to HYAL1

1 reference

12 December 2020

10.1016/J.JURO.2009.06.070

Identifiers

DOI

1 reference

10 September 2017

1 reference

10 September 2017

PubMed publication ID

19683287

1 reference